LSW EVS Event
Executive Insights Series – Life Sciences Finances: Keys for Attracting Investment – From Series A to IPO
Founded in 2011, Absci has grown from a basement lab at Portland State University’s business accelerator into a publicly traded leader in AI-driven drug discovery. Under founder and CEO Sean McClain, the company progressed from a 2016 Series A to a 2021 IPO on NASDAQ with a $2B market cap, and now operates from an […]
SBIR Grant Writing Training
With the recent reauthorization of the Small Business Innovation Research (SBIR) program, now is a critical time for life science companies to revisit non-dilutive funding opportunities. Applying for grants can be an overwhelming process, let us make it easier for you! On May 19, join us for a free virtual workshop where Natalie Rudolph and […]
Executive Insights Series – Demystifying Strategic Partnerships In Life Sciences
Strategic partnerships are essential for accelerating innovation, bridging the gap between scientific discovery and commercialization, and navigating complex market dynamics. Join us in person for this Executive Insight Series session, focused on navigating early-stage partnerships and collaborations in life sciences. Lila Hope, Partner at Cooley, and Jie D’Elia, CEO of Systimmune, will explore the mechanics […]